Scholarlink

<p>Atrial fibrillation (AF) is a leading cause of cardiovascular disease. Women have a higher risk of AF-related stroke and poorer outcomes than men. Despite this, women are underrepresented in anticoagulation trials and receive fewer advanced interventions. Many studies lack sex-specific data. Emerging evidence suggests early anticoagulation after AF-related stroke may benefit women more, emphasizing the need for sex-stratified data to improve risk prediction, identify key biomarkers, and optimize treatment.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Atrial fibrillation and thromboembolic stroke risk in women

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月19日

查看全文
  • Alexis B. McAlister,
  • Louise D. McCullough,
  • Maria A. Parekh

摘要

Atrial fibrillation (AF) is a leading cause of cardiovascular disease. Women have a higher risk of AF-related stroke and poorer outcomes than men. Despite this, women are underrepresented in anticoagulation trials and receive fewer advanced interventions. Many studies lack sex-specific data. Emerging evidence suggests early anticoagulation after AF-related stroke may benefit women more, emphasizing the need for sex-stratified data to improve risk prediction, identify key biomarkers, and optimize treatment.